EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Characteristics and clinical outcomes of nirmatrelvir/ritonavir (PaxlovidTM) recipients in Canada, 2022: a descriptive cohort study

Nadine Sicard, Susan Squires, Muhammad Mullah, Peter Daley

Canada Communicable Disease Report · 20.11.2023 · 49 (10) · 440-445

DOI: 10.14745/ccdr.v49i10a05 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Canada Communicable Disease Report, online erschienen am 20.11.2023. Verfasst von Nadine Sicard und 3 weiteren Autor:innen. Beteiligte Einrichtung: Public Health Agency of Canada, Infectious Disease Programs Branch, Montréal, QC. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

COVID-19Paxlovidantiviral therapyhealth databasesnirmatrelvir/ritonavirprovincial summary data

Autor:innen und Institutionen

  • Public Health Agency of Canada, Infectious Disease Programs Branch, Montréal, QC.
  • Public Health Agency of Canada, Infectious Disease Programs Branch, Ottawa, ON.
  • Public Heath Agency of Canada, Centre for Communicable Diseases and Infection Control, Ottawa, ON.
  • Memorial University of Newfoundland, Faculty of Medicine, Division of Infectious Diseases, St. John's, NL.

Zitieren

APA

Sicard, N., Squires, S., Mullah, M., & Daley, P. (2023). Characteristics and clinical outcomes of nirmatrelvir/ritonavir (PaxlovidTM) recipients in Canada, 2022: a descriptive cohort study. Canada Communicable Disease Report, 49(10), 440-445. https://doi.org/10.14745/ccdr.v49i10a05

Vancouver

Sicard N, Squires S, Mullah M, Daley P. Characteristics and clinical outcomes of nirmatrelvir/ritonavir (PaxlovidTM) recipients in Canada, 2022: a descriptive cohort study. Canada Communicable Disease Report. 2023;49(10):440-445. doi:10.14745/ccdr.v49i10a05

BibTeX
@article{Sicard2023,
  author = {Sicard, Nadine and Squires, Susan and Mullah, Muhammad and Daley, Peter},
  title = {Characteristics and clinical outcomes of nirmatrelvir/ritonavir (PaxlovidTM) recipients in Canada, 2022: a descriptive cohort study},
  journal = {Canada Communicable Disease Report},
  year = {2023},
  volume = {49},
  number = {10},
  pages = {440--445},
  doi = {10.14745/ccdr.v49i10a05}
}
Kostenlos starten →